Search results for "Human medicine"

showing 10 items of 256 documents

Cancer and the microbiome : potential applications as new tumor biomarker

2015

Abstract: Microbial communities that colonize in humans are collectively described as microbiome. According to conservative estimates, about 15% of all types of neoplasms are related to different infective agents. However, current knowledge is not sufficient to explain how the microbiome contributes to the growth and development of cancers. Large and thorough studies involving colonized, diverse and complex microbiome entities are required to identify microbiome as a potential cancer marker and to understand how the immune system is involved in response to pathogens. This article reviews the existing evidence supporting the enigmatic association of transformed microbiome with the developmen…

RiskComputational biologyBiologycancer biomarkerImmune systemcancer diagnosisNeoplasmstransformed microbiomemedicineBiomarkers TumorAnimalsHumansPharmacology (medical)Microbiomecancer biomarker; cancer diagnosis; cancer prevention; immunological modification; transformed microbiome; Animals; Biomarkers; Tumor; Humans; Neoplasms; Risk; Microbiota; Oncology; Pharmacology (medical)Cancer markercancer diagnosiimmunological modificationCancer preventionTumorcancer preventionAnimalMicrobiotaCancermedicine.diseaseBiomarkercancer biomarker; cancer diagnosis; cancer prevention; immunological modification; transformed microbiome; Animals; Biomarkers Tumor; Humans; Neoplasms; Risk; Microbiota; Oncology; Pharmacology (medical)OncologyImmunologyNeoplasmHuman medicineBiomarkersHumanExpert review of anticancer therapy
researchProduct

Experimentally Induced Biliary Atresia by Means of Rotavirus‐Infection Is Directly Linked to Severe Damage of the Microvasculature in the Extrahepati…

2018

Abstract: Vascular damage has been reported to contribute to atresia formation in several diseases including biliary atresia. This study focused on the extrahepatic biliary plexus in experimental biliary atresia. Newborn BALB/cAnNCrl-pups were infected with rhesus rotavirus within 24 hr after birth to induce experimental biliary atresia. The extrahepatic biliary plexus was examined by confocal microscopy on whole-mount preparations, scored by three independent researchers, and further evaluated at the subcellular level with transmission electron microscopy. Imaging results revealed a progressive destruction of the extrahepatic biliary vascular plexus in the course of experimental biliary at…

Rotavirus0301 basic medicinePathologymedicine.medical_specialtyHistologyNecrosismedicine.disease_causeRotavirus InfectionsMicrocirculationPathogenesisMice03 medical and health sciences0302 clinical medicineMicroscopy Electron TransmissionBile Ducts ExtrahepaticBiliary AtresiaBiliary atresiaRotavirusmedicineAnimalsHumansEcology Evolution Behavior and SystematicsMice Inbred BALB CPlexusMicroscopy Confocalbusiness.industryBile ductmedicine.diseaseDisease Models Animal030104 developmental biologymedicine.anatomical_structureAnimals NewbornAtresiaMicrovesselsDisease ProgressionFemaleHuman medicineAnatomymedicine.symptombusiness030217 neurology & neurosurgeryBiotechnologyThe Anatomical Record
researchProduct

PLEKHM1 Regulates Salmonella-Containing Vacuole Biogenesis and Infection

2015

Abstract: The host endolysosomal compartment is often manipulated by intracellular bacterial pathogens. Salmonella (Salmonella enterica serovar Typhimurium) secrete numerous effector proteins, including SifA, through a specialized type III secretion system to hijack the host endosomal system and generate the Salmonella-containing vacuole (SCV). To form this replicative niche, Salmonella targets the Rab7 GTPase to recruit host membranes through largely unknown mechanisms. We show that Pleckstrin homology domain-containing protein family member 1 (PLEKHM1), a lysosomal adaptor, is targeted by Salmonella through direct interaction with SifA. By binding the PLEKHM1 PH2 domain, Salmonella utiliz…

SalmonellaCancer ResearchbiologyEffectorEndosomeVacuolebiology.organism_classificationmedicine.disease_causeMicrobiologyType three secretion systemMicrobiologyPleckstrin homology domainSalmonella entericaVirologyImmunology and Microbiology(all)medicineParasitologySecretionHuman medicineBiologyMolecular BiologyCell Host & Microbe
researchProduct

Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy

2021

Abstract Synaptic inhibition is essential for shaping the dynamics of neuronal networks, and aberrant inhibition is linked to epilepsy. Gephyrin (Geph) is the principal scaffolding protein at inhibitory synapses and is essential for postsynaptic clustering of glycine (GlyRs) and GABA type A receptors. Consequently, gephyrin is crucial for maintaining the relationship between excitation and inhibition in normal brain function and mutations in the gephyrin gene (GPHN) are associated with neurodevelopmental disorders and epilepsy. We identified bi-allelic variants in the GPHN gene, namely the missense mutation c.1264G > A and splice acceptor variant c.1315-2A > G, in a patient wi…

Scaffold proteinBiologyInhibitory postsynaptic potentialEpilepsyPostsynaptic potentialGeneticsmedicineHumansMissense mutationReceptorBiologyMolecular BiologyGenetics (clinical)Brain DiseasesEpilepsyGephyrinMembrane ProteinsGeneral MedicineReceptors GABA-Amedicine.diseaseCell biologyChemistrySynapsesbiology.proteinHuman medicineReceptor clusteringCarrier ProteinsHuman Molecular Genetics
researchProduct

The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study

2022

Abstract Background Injury remains a major concern to public health in the European region. Previous iterations of the Global Burden of Disease (GBD) study showed wide variation in injury death and disability adjusted life year (DALY) rates across Europe, indicating injury inequality gaps between sub-regions and countries. The objectives of this study were to: 1) compare GBD 2019 estimates on injury mortality and DALYs across European sub-regions and countries by cause-of-injury category and sex; 2) examine changes in injury DALY rates over a 20 year-period by cause-of-injury category, sub-region and country; and 3) assess inequalities in injury mortality and DALY rates across the countries…

Science & TechnologyInjuriesDEATHSPublic Health Environmental and Occupational HealthBurden of diseasePublic Health Global Health Social Medicine and Epidemiology3121 Internal medicineBurden of disease; Injuries; Disability adjusted life years; Mortality; Europe3142 Public health care science environmental and occupational health1117 Public Health and Health ServicesInjurieDisability adjusted life yearsEuropeFolkhälsovetenskap global hälsa socialmedicin och epidemiologiSDG 3 - Good Health and Well-beingINEQUALITIESPublic HealthHuman medicineDisability adjusted life yearMortalityLife Sciences & BiomedicinePublic Environmental & Occupational Health
researchProduct

HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma

2015

Abstract: The diagnosis and treatment of hepatocellular carcinoma (HCC) underwent a huge advancement in the last years. Recently, microRNAs (miRNAs) have been also studied to provide a new tool for early diagnosis of high risk patients, for prognostic classification to identify those patients who benefit cancer treatment and for predictive definition to select the right targeted drug. In this review we revised all the available data obtained to explore the role of miRNAs in HCC. This analysis led to identification of miRNAs which could gain a diagnostic, prognostic or predictive role. The results of studies on miRNAs involved in HCC are initial and far from providing scientific evidences to…

Serum0301 basic medicineCarcinoma HepatocellularHepatocellular carcinomaPrognosimedicine.medical_treatmentBioinformaticsTargeted therapyTargeted therapy03 medical and health sciences0302 clinical medicinePrognostic classificationBiomarkers TumormedicineHumansProspective cohort studyHigh risk patientsbusiness.industryLiver NeoplasmsMicroRNAHematologyPrognosismedicine.diseaseCancer treatmentClinical PracticeMicroRNAs030104 developmental biologyOncology030220 oncology & carcinogenesisHepatocellular carcinomaHuman medicineDiagnosis; Hepatocellular carcinoma; MicroRNA; Prognosis; Serum; Targeted therapy; Hematology; Oncology; Geriatrics and GerontologyGeriatrics and GerontologybusinessDiagnosiCritical Reviews in Oncology/Hematology
researchProduct

The synergistic effect of SAHA and parthenolide in MDA-MB231 breast cancer cells

2014

Abstract: The sesquiterpene lactone Parthenolide (PN) exerted a cytotoxic effect on MDA-MB231 cells, a triple-negative breast cancer (TNBC) cell line, but its effectiveness was scarce when employed at low doses. This represents an obstacle for a therapeutic utilization of PN. In order to overcome this difficulty we associated to PN the suberoylanilide hydroxamic acid (SAHA), an histone deacetylase inhibitor. Our results show that SAHA synergistically sensitized MDA-MB231 cells to the cytotoxic effect of PN. It is noteworthy that treatment with PN alone stimulated the survival pathway Akt/mTOR and the consequent nuclear translocation of Nrf2, while treatment with SAHA alone induced autophagi…

SesquiterpenePhysiologyClinical BiochemistryDown-RegulationApoptosisBreast NeoplasmsApoptosis; Autophagy; Breast Neoplasms; Cell Line Tumor; Down-Regulation; Drug Synergism; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; NF-kappa B; Sesquiterpenes; Clinical Biochemistry; Cell Biology; Physiology; Medicine (all)Hydroxamic AcidsHydroxamic AcidSettore BIO/10 - BiochimicaCell Line TumorHistone Deacetylase InhibitorAutophagyHumansBiologyVorinostatMedicine (all)NF-kappa BApoptosiDrug SynergismCell BiologyHistone Deacetylase InhibitorsFemaleHuman medicineSesquiterpenesBreast NeoplasmHumanJournal of cellular physiology
researchProduct

Aging and chronic inflammation: highlights from a multidisciplinary workshop

2023

Abstract: Aging is a gradual, continuous series of natural changes in biological, physiological, immunological, environmental, psychological, behavioral, and social processes. Aging entails changes in the immune system characterized by a decrease in thymic output of naïve lymphocytes, an accumulated chronic antigenic stress notably caused by chronic infections such as cytomegalovirus (CMV), and immune cell senescence with acquisition of an inflammatory senescence-associated secretory phenotype (SASP). For this reason, and due to the SASP originating from other tissues, aging is commonly accompanied by low-grade chronic inflammation, termed “inflammaging”. After decades of accumulating evide…

Settore MED/04 - Patologia GeneraleAgingBiomodulina TImmunosenescenceCell senescenceSenolyticHuman medicineChronic inflammationSASPBiologyInflammagingMetformin
researchProduct

An Instrument-Assisted coracoid pain test: an exploratory diagnostic accuracy study

2022

The coracoid pain test (CPT) could contribute to the diagnosis of frozen shoulder (FS) with palpation. However, due to assessor performance these values might be unreliable. Therefore, the aim was to explore the diagnostic accuracy of an instrument-assisted CPT and two alternative approaches (pain severity and side comparison) for assistance in the diagnosis of FS. Patients with FS and healthy age-matched controls were recruited. All participants underwent the instrument-assisted CPT on both shoulders with a pressure algometer. Sensitivity, specificity, and likelihood ratios were determined for the three approaches. In total, 35 patients with FS and 35 healthy participants were included. Th…

ShoulderFisioteràpiaFerides i lesions TractamentHealth Toxicology and MutagenesisPublic Health Environmental and Occupational HealthPainSensitivity and Specificityfrozen shoulder; diagnostic test accuracy; coracoid pain test; diagnostic testsExtremitatsChemistryCross-Sectional StudiesDiagnòsticBursitisHumansHuman medicineBiology
researchProduct

The role of targeted therapy for gastrointestinal tumors

2014

Abstract: Many targeted drugs have been studied to target the molecular pathways involved in the development of gastrointestinal cancers. Anti-VEGF, anti-EGFR agents, and recently also multi-kinase inhibitor regorafenib, have already been available for the treatment of metastatic colorectal cancer patients. To date, Her-2 positive, gastric cancer patients, are also treated with trastuzumab, while the multi-targeted inhibitor, sorafenib, represents the standard treatment for hepatocellular carcinoma patients. Finally, sunitinib and everolimus, have been approved for the treatment of the neuroendocrine gastroenteropancreatic tumors. Actually a great number of further drugs are under preclinic…

SorafenibOncologyVascular Endothelial Growth Factor Amedicine.medical_specialtyReceptor ErbB-2Hepatocellular carcinomaSettore MED/06 - Oncologia Medicamedicine.medical_treatmentAntineoplastic AgentsNeuroendocrine tumorsTargeted therapyTargeted therapychemistry.chemical_compoundNeuroendocrine tumorTrastuzumabInternal medicineRegorafenibmedicineHumansGastrointestinal tumorsMolecular Targeted TherapyProtein Kinase InhibitorsGastrointestinal NeoplasmsEverolimusHepatologySunitinibbusiness.industryColorectal cancer; Gastric cancer; Gastrointestinal tumors; Hepatocellular carcinoma; Neuroendocrine tumors; Targeted therapy; Hepatology; GastroenterologyGastrointestinal tumorGastroenterologyCancermedicine.diseaseColorectal cancerErbB ReceptorsReceptors Vascular Endothelial Growth FactorchemistryHuman medicineNeuroendocrine tumorsbusinessGastric cancermedicine.drug
researchProduct